The fresh suspensions were a major blow to a global immunisation campaign that experts hope will help end a year-long pandemic that has already killed over 2.6 million people and decimated the global economy.
The pandemic scenario in Africa is taking on grim proportions as each day passes. Africa makes up about 3.3 per cent of the global total of confirmed virus cases, but this is believed to be just a fraction of the actual cases on the continent of 1.3 billion people.
Earlier this week, there was a public outpouring of emotion as Maggie Keenan, aged 90, was the first person to receive a COVID-19 vaccine in the UK. With effective vaccines coming to market, the end of the pandemic could be within our sight.
Britain’s government said on Sunday it would give financial aid to airports before the end of March, after the industry called for urgent support as tighter COVID-19 rules for international travellers start on Monday.
The announcement comes as the Ministry of Health and Prevention on Sunday expanded coronavirus vaccine eligibility in line with the UAE's proactive policy to ensure the health and safety of all community members.
This is with reference to the COVID-19 vaccination drive in India. Covishield has been developed by Oxford University and AstraZeneca. Covaxin has been produced by Bharat Biotech. The Phase 3 trials of Covaxin are not yet complete. Hence some doctors and health
Britain now has the worst Covid death rate in the world, due in large part to Boris Johnson’s fatal refusal to make decisions in time, from the late lockdown in March last year to the delayed announcement of Covid PCR tests on arrivals into the UK
Serum Institue of India's CEO, Adar Poonwala, said he was “deeply saddened” by the loss of life. He said there would be no reduction in vaccine manufacturing because the company has other available facilities.
The Dubai Health Authority (DHA) announced on Wednesday that it has started providing the Oxford-AstraZeneca COVID19 vaccine to certain groups of people in Dubai.